Ιατρική Σχολή / Medical School: Recent submissions

Now showing items 1001-1020 of 1246

    • Article  

      Developing Measures of Pathways that May Link Macro Social/Structural Changes with HIV Epidemiology 

      Pouget, E. R.; Sandoval, M.; Nikolopoulos, Georgios K.; Mateu-Gelabert, Pedro; Rossi, D.; Smyrnov, P.; Jones, Yolanda; Friedman, Samuel R. (2016)
      Macro-social/structural events (“big events”) such as wars, disasters, and large-scale changes in policies can affect HIV transmission by making risk behaviors more or less likely or by changing risk contexts. The purpose ...
    • Article  

      ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 

      Dittrich, Christian; Kosty, Michael P.; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo G.; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; Petris, Luigi De; Santis, Maria De; Vries, Elisabeth G. E. de; Dizon, Don S.; Duff, Jennifer; Duska, Linda R.; Eniu, Alexandru; Ernstoff, Marc; Felip, Enriqueta; Fey, Martin F.; Gilbert, Jill; Girard, Nicolas; Glaudemans, Andor W. J. M.; Gopalan, Priya K.; Grothey, Axel; Hahn, Stephen M.; Hanna, Diana; Herold, Christian; Herrstedt, Jørn; Homicsko, Krisztian; Jones, Dennie V.; Jost, Lorenz M.; Keilholz, Ulrich; Khan, Saad; Kiss, Alexander; Köhne, Claus-Henning; Kunstfeld, Rainer; Lenz, Heinz-Josef; Lichtman, Stuart; Licitra, Lisa; Lion, Thomas; Litière, Saskia; Liu, Lifang; Loehrer, Patrick J.; Markham, Merry Jennifer; Markman, Ben; Mayerhoefer, Marius; Meran, Johannes G.; Michielin, Olivier; Moser, Elizabeth Charlotte; Mountzios, Giannis; Moynihan, Timothy; Nielsen, Torsten; Ohe, Yuichiro; Öberg, Kjell; Palumbo, Antonio; Peccatori, Fedro A.; Pfeilstöcker, Michael; Raut, Chandrajit; Remick, Scot C.; Robson, Mark; Rutkowski, Piotr; Salgado, Roberto; Schapira, Lidia; Schernhammer, Eva; Schlumberger, Martin; Schmoll, Hans-Joachim; Schnipper, Lowell; Sessa, Cristiana; Shapiro, Charles L.; Steele, Julie; Sternberg, Cora N.; Stiefel, Friedrich; Strasser, Florian; Stupp, Roger; Sullivan, Richard; Tabernero, Josep; Travado, Luzia; Verheij, Marcel; Voest, Emile; Vokes, Everett; Roenn, Jamie Von; Weber, Jeffrey S.; Wildiers, Hans; Yarden, Yosef (2016)
      The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) thanks to contribution of 64 ESMO-appointed and 32 ...
    • Article  

      Effect of letrozole on the lipid profile in postmenopausal women with breast cancer 

      Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Kakaidi, B.; Tzallas, C. S.; Katsaraki, A.; Pavlidis, Nicholas (2001)
      Hormonal therapy plays a central role in the overall treatment of breast cancer. Aromatase inhibitors can inhibit the aromatase enzyme system resulting in a reduction of oestrogens. Letrozole is a non-steroidal aromatase ...
    • Article  

      Favorable outcome in non-Hodgkin lymphoma of the maxillary sinus treated with R-CHOP 

      Doumas, Stergios; Sakkas, L.; Panayiotidis, P.; Wozniak, Greta; Vlychou, M.; Vassilopoulos, G. (2014)
    • Article  

      Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer 

      Economopoulou, P.; Mountzios, G.; Pavlidis, Nicholas; Pentheroudakis, George (2015)
      Cancer of Unknown Primary (CUP) comprises a heterogeneous disease group with diagnosis of metastatic malignancy in the absence of an identifiable primary site after diagnostic work up. CUP may either resemble a specific ...
    • Article  

      Rituximab in combination with CNOP chemotherapy in patients withn previously untreated indolent non-Hodgkin's lymphoma 

      Economopoulos, T.; Fountzilas, George; Pavlidis, Nicholas; Kalantzis, Dimitrios; Papageorgiou, E.; Christodoulou, C.; Hamilos, G.; Nikolaides, C.; Dimopoulos, M. A. (2003)
      Rituximab, a chimeric monoclonal antibody, produces response rates of up to 73% in patients with previously untreated indolent non-Hodgkin's lymphoma (NHL), and has high activity when combined with chemotherapy. The purpose ...
    • Article  

      Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma 

      Polyzoidis, K. S.; Miliaras, G.; Pavlidis, Nicholas (2005)
      The diagnosis of a brain metastasis is usually made during the routine follow up examinations of patients with known cancer, who are under the care of oncology departments. The involvement of the neurosurgeon depends on ...
    • Article  

      Primary extranodal non-hodgkin's lymphoma of the head and neck 

      Economopoulos, T.; Asprou, N.; Stathakis, N.; Fountzilas, George; Pavlidis, Nicholas; Papaspyrou, S.; Dervenoulas, John; Belia, M.; Papageorgiou, E.; Theoharis, D.; Vrettou, E.; Raptis, S. (1992)
      Among 387 cases of non-Hodgkin's lymphoma (NHL) treated in our units between January 1977 and December 1990, 52 (13.4%) had primary extranodal (PE) NHL of the head and neck. The median age was 55 years with a M:F ratio of ...
    • Article  

      Do LH-RH analogues induce effects similar to tamoxifen on serum lipid parameters in premenopausal women with breast cancer? A prospective study 

      Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Fountzilas, George; Tzallas, C. S.; Tsolas, O.; Siamopoulos, K. C.; Pavlidis, Nicholas (1998)
      Background and Aim: As a continuation of our investigational program we carried out the present study to evaluate and compare the impact of LH-RH analogues and tamoxifen on serum lipid parameters in premenopausal women ...
    • Article  

      Global curriculum edition 2016: European society for medical oncology/American society of clinical oncology recommendations for training in medical oncology 

      Dittrich, C.; Kosty, M. P.; Jezdic, S.; Pyle, D.; Berardi, Rossana; Bergh, Jonas; Nagi, S. E.-S.; Lotz, J. P.; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta (2017)
    • Article  

      The correlation among positive B cell crossmatch; MLC blockade, and graft survival in kidney transplant recipients 

      Esquenazi, V.; Kyriakides, George K.; Flaa, C.; Fuller, L.; Miller, Jody C. (1983)
    • Article  

      Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP 

      Economopoulos, T.; Dimopoulos, M. A.; Mellou, S.; Pavlidis, Nicholas; Samantas, E.; Nikolaides, C.; Tsatalas, C.; Papadopoulos, A.; Papageorgiou, E.; Papasavvas, P.; Fountzilas, George (2002)
      Introduction: During the last few years epirubicin (E) and mitoxantrone (M) (Novantrone) have been used in the treatment of non-Hodgkin's lymphoma (NHL), because of their favorable principal profile. In particular, M has ...
    • Article  

      Immediate impact of Hurricane Sandy on people who inject drugs in New York City 

      Pouget, E. R.; Sandoval, M.; Nikolopoulos, Georgios K.; Friedman, Samuel R. (2015)
      Over the eight months following Hurricane Sandy, of October 2012, we interviewed 300 people who inject drugs in New York City. During the week after the storm, 28% rescued others or volunteered with aid groups; 60% experienced ...
    • Article  

      Second malignancies following treatment for Hodgkin's disease: A Greek experience 

      Economopoulos, T.; Stathakis, N.; Alexopoulos, C.; Pavlidis, Nicholas; Constantinidou, M.; Briassoulis, E. Ch; Papageorgiou, E.; Dervenoulas, John; Pappa, Vassiliki; Vaslamatzis, M.; Raptis, S. (1994)
      The risk and the type of second malignancies (SM) developing in 217 treated Hodgkin's disease (HD) patients were studied. The median age of the patients was 35 years (range 14-83) and the M/F ratio 1.8. Treatment consisted ...
    • Article  

      Simultaneous targeting of multiple opioid receptors: A strategy to improve side-effect profile 

      Dietis, Nikolas; Guerrini, R.; Calo, G.; Salvadori, S.; Rowbotham, D. J.; Lambert, D. G. (2009)
      Opioid receptors are currently classified as (mu: mOP), δ (delta: dOP), κ (kappa: kOP) with a fourth related non-classical opioid receptor for nociceptin/orphainin FQ, NOP. Morphine is the current gold standard analgesic ...
    • Article  

      Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: A hellenic cooperative oncology group study 

      Dimopoulos, M. A.; Papadopoulou, M.; Andreopoulou, E.; Papadimitriou, C.; Pavlidis, Nicholas; Aravantinos, Gerasimos; Aspropotamitis, A.; Anagnostopoulos, A.; Fountzilas, George; Michalas, S.; Pectasides, Dimitrios (1998)
      Purpose. To evaluate the outcome and the prognosis of patients with ovarian germ cell malignancies who were treated with platinum-based chemotherapy immediately after initial surgery. Methods. We conducted a retrospective ...
    • Article  

      Fcγ receptor polymorphisms and their association with periodontal disease: A meta-analysis 

      Dimou, Niki L.; Nikolopoulos, Georgios K.; Hamodrakas, Stavros J.; Bagos, Pantelis G. (2010)
      Aim: A systematic review and a meta-analysis were conducted in order to investigate the potential association of Fcγ receptor (FcγR) polymorphisms with susceptibility to aggressive and chronic periodontal disease. Materials ...
    • Article  

      ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016 

      Dittrich, C.; Kosty, M.; Jezdic, S.; Pyle, D.; Berardi, Rossana; Bergh, Jonas; Saghir, Nagi El; Lotz, J. P.; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta (2016)
    • Article  

      Fc gamma receptor polymorphisms and their association with periodontal disease: a meta-analysis 

      Dimou, Niki L.; Nikolopoulos, Georgios K.; Hamodrakas, Stavros J.; Bagos, Pantelis G. (2010)
      Aim: A systematic review and a meta-analysis were conducted in order to investigate the potential association of Fc gamma receptor (Fc gamma R) polymorphisms with susceptibility to aggressive and chronic periodontal disease. ...
    • Article  

      Controlling cancer pain: Is morphine the best we can do? 

      Dietis, Nikolas; Rowbotham, D. J.; Lambert, D. G. (2011)
      Despite the existence of a family of 3 classical and one non-classical opioid receptor, morphine, acting at the MOP (μ) receptor remains the gold standard for use in cancer pain. The main thrust of opioid development has ...